The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC) with preserved liver function.
 
Autumn Jackson McRee
Honoraria - Cor2Ed
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Rgenix (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Cor2Ed
 
Paul R. Helft
No Relationships to Disclose
 
William Proctor Harris
Consulting or Advisory Role - BD Medical; Bristol-Myers Squibb; Eisai; Exelixis; Merck; Merck; Neo Therma; QED therapeutics; Zymeworks
Research Funding - Agios (Inst); ArQule (Inst); Bayer (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); BTG (Inst); Exelixis (Inst); Halozyme (Inst); Koo Foundation (Inst); MedImmune (Inst); Merck (Inst); zymeworks (Inst)
Travel, Accommodations, Expenses - Eisai
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst)
 
Matthew Johnson
Stock and Other Ownership Interests - Endoshape; FluidX
Consulting or Advisory Role - Argon Medical Devices; Boston Scientific; Cook Medical
Research Funding - Argon Medical Devices; Black Swan Health; Boston Scientific
Expert Testimony - Argon Medical Devices
 
Menggang Yu
Consulting or Advisory Role - Merck
 
Bert O'Neil
Employment - Lilly
Honoraria - AstraZeneca